2023 Q2 Form 10-Q Financial Statement

#000137536523000028 Filed on May 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $2.185B $1.283B
YoY Change 33.59% -5.33%
Cost Of Revenue $1.813B $1.057B
YoY Change 34.5% -7.67%
Gross Profit $371.7M $226.4M
YoY Change 29.36% 7.39%
Gross Profit Margin 17.01% 17.64%
Selling, General & Admin $60.14M $49.76M
YoY Change 17.14% -0.73%
% of Gross Profit 16.18% 21.98%
Research & Development $84.80M $77.52M
YoY Change 19.79% 9.38%
% of Gross Profit 22.81% 34.24%
Depreciation & Amortization $9.000M $8.736M
YoY Change 6.86% 4.4%
% of Gross Profit 2.42% 3.86%
Operating Expenses $144.9M $127.3M
YoY Change 18.68% 5.19%
Operating Profit $226.8M $99.08M
YoY Change 37.25% 10.36%
Interest Expense -$3.509M $1.288M
YoY Change 19.84% -15.87%
% of Operating Profit -1.55% 1.3%
Other Income/Expense, Net $2.005M -$78.00K
YoY Change -49.53% -101.67%
Pretax Income $225.3M $97.72M
YoY Change 35.48% 5.17%
Income Tax $31.30M $10.90M
% Of Pretax Income 13.9% 11.15%
Net Earnings $193.6M $85.85M
YoY Change 37.46% 11.53%
Net Earnings / Revenue 8.86% 6.69%
Basic Earnings Per Share $1.61
Diluted Earnings Per Share $3.43 $1.53
COMMON SHARES
Basic Shares Outstanding 52.49M shares 53.64M shares
Diluted Shares Outstanding 56.23M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $440.5M $362.8M
YoY Change 64.72% 46.63%
Cash & Equivalents $440.5M $362.8M
Short-Term Investments
Other Short-Term Assets $145.1M $139.9M
YoY Change 1989.0% 493.2%
Inventory $1.446B $1.540B
Prepaid Expenses $8.724M
Receivables $1.148B $672.1M
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.179B $2.715B
YoY Change 13.3% 1.36%
LONG-TERM ASSETS
Property, Plant & Equipment $290.2M $290.0M
YoY Change 1.49% 2.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.494M
YoY Change -47.8%
Other Assets $205.1M $38.83M
YoY Change 446.37% -0.04%
Total Long-Term Assets $495.3M $477.4M
YoY Change 24.21% 21.65%
TOTAL ASSETS
Total Short-Term Assets $3.179B $2.715B
Total Long-Term Assets $495.3M $477.4M
Total Assets $3.675B $3.193B
YoY Change 14.65% 3.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $776.8M $641.8M
YoY Change 18.53% -17.67%
Accrued Expenses $163.9M $155.2M
YoY Change -22.86% -14.45%
Deferred Revenue $134.7M $148.7M
YoY Change 20.98% 29.7%
Short-Term Debt $170.1M $0.00
YoY Change -62.12% -100.0%
Long-Term Debt Due $170.1M $53.97M
YoY Change -62.12% -86.61%
Total Short-Term Liabilities $1.375B $1.092B
YoY Change -6.49% -26.99%
LONG-TERM LIABILITIES
Long-Term Debt $120.2M $133.2M
YoY Change -18.59% -7.75%
Other Long-Term Liabilities $207.7M $37.24M
YoY Change 430.73% -10.52%
Total Long-Term Liabilities $327.9M $170.5M
YoY Change 75.58% -8.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.375B $1.092B
Total Long-Term Liabilities $327.9M $170.5M
Total Liabilities $1.703B $1.424B
YoY Change -4.31% -20.77%
SHAREHOLDERS EQUITY
Retained Earnings $1.433B $1.239B
YoY Change 51.98% 54.52%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.972B $1.768B
YoY Change
Total Liabilities & Shareholders Equity $3.675B $3.193B
YoY Change 14.65% 3.95%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $193.6M $85.85M
YoY Change 37.46% 11.53%
Depreciation, Depletion And Amortization $9.000M $8.736M
YoY Change 6.86% 4.4%
Cash From Operating Activities -$9.300M $198.2M
YoY Change -63.01% -186.97%
INVESTING ACTIVITIES
Capital Expenditures $8.200M $7.987M
YoY Change -174.38% -172.93%
Acquisitions
YoY Change
Other Investing Activities -$2.700M $0.00
YoY Change
Cash From Investing Activities -$10.90M -$7.987M
YoY Change -1.13% -27.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 99.00M -131.5M
YoY Change 75.2% -154.96%
NET CHANGE
Cash From Operating Activities -9.300M 198.2M
Cash From Investing Activities -10.90M -7.987M
Cash From Financing Activities 99.00M -131.5M
Net Change In Cash 78.80M 58.79M
YoY Change 287.45% 19174.75%
FREE CASH FLOW
Cash From Operating Activities -$9.300M $198.2M
Capital Expenditures $8.200M $7.987M
Free Cash Flow -$17.50M $190.3M
YoY Change 23.96% -187.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001375365
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33383
dei Entity Registrant Name
EntityRegistrantName
Super Micro Computer, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0353939
dei Entity Address Address Line1
EntityAddressAddressLine1
980 Rock Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
San Jose
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95131
dei City Area Code
CityAreaCode
408
dei Local Phone Number
LocalPhoneNumber
503-8000
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
SMCI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
52488494 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
362801000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
267397000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
672055000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
834513000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
1540419000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
1545606000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
139900000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
158799000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
2715175000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
2806315000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
290038000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
285972000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
148558000 usd
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
69929000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
38833000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
42861000 usd
CY2023Q1 us-gaap Assets
Assets
3192604000 usd
CY2022Q2 us-gaap Assets
Assets
3205077000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
641839000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
655403000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
155224000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
212419000 usd
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
92598000 usd
CY2022Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
41743000 usd
CY2023Q1 smci Short Term Debt And Long Term Debt Current Maturities
ShortTermDebtAndLongTermDebtCurrentMaturities
53972000 usd
CY2022Q2 smci Short Term Debt And Long Term Debt Current Maturities
ShortTermDebtAndLongTermDebtCurrentMaturities
449146000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
148747000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
111313000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1092380000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1470024000 usd
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
161176000 usd
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
122548000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
133235000 usd
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
147618000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
37240000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
39140000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1424031000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
1779330000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1768573000 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52484000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52311000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52484000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52311000 shares
CY2023Q1 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
528279000 usd
CY2022Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
481741000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
683000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
911000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1239445000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
942923000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1768407000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1425575000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
166000 usd
CY2022Q2 us-gaap Minority Interest
MinorityInterest
172000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1425747000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3192604000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3205077000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1283296000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1355490000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4938621000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3560639000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
1056937000 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
1144715000 usd
us-gaap Cost Of Revenue
CostOfRevenue
4027305000 usd
us-gaap Cost Of Revenue
CostOfRevenue
3047982000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
226359000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
210775000 usd
us-gaap Gross Profit
GrossProfit
911316000 usd
us-gaap Gross Profit
GrossProfit
512657000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
77515000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
70869000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
222458000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
201483000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
25312000 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
22356000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
83120000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
65940000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24450000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27773000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
71351000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
75280000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
127277000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
120998000 usd
us-gaap Operating Expenses
OperatingExpenses
376929000 usd
us-gaap Operating Expenses
OperatingExpenses
342703000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
99082000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
89777000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
534387000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
169954000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-78000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4663000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1641000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4106000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
1288000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
1531000 usd
us-gaap Interest Expense
InterestExpense
6982000 usd
us-gaap Interest Expense
InterestExpense
3485000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
97716000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
92909000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
529046000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
170575000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10857000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16192000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
79364000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27116000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1013000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
255000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3253000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
882000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
85846000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
76972000 usd
us-gaap Net Income Loss
NetIncomeLoss
446429000 usd
us-gaap Net Income Loss
NetIncomeLoss
144341000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.61
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.82
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.53
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.43
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.70
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53280000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51708000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53011000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51269000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56233000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53786000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55796000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53401000 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
85846000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
76972000 usd
us-gaap Net Income Loss
NetIncomeLoss
446429000 usd
us-gaap Net Income Loss
NetIncomeLoss
144341000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
71000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
5000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-228000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
101000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
71000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-228000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
101000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
85917000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
76977000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
446201000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
144442000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1818842000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9495000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-8938000 usd
CY2023Q1 smci Stock Repurchased And Retired During Period Including Related Taxes Value
StockRepurchasedAndRetiredDuringPeriodIncludingRelatedTaxesValue
150396000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13652000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
71000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
85847000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1768573000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1186845000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4363000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-2006000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7741000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
76971000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1273919000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1425747000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
24822000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-19442000 usd
smci Stock Repurchased And Retired During Period Including Related Taxes Value
StockRepurchasedAndRetiredDuringPeriodIncludingRelatedTaxesValue
150396000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
41647000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-228000 usd
us-gaap Profit Loss
ProfitLoss
446423000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1768573000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1096398000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15951000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-6807000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23932000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
101000 usd
us-gaap Profit Loss
ProfitLoss
144344000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1273919000 usd
us-gaap Net Income Loss
NetIncomeLoss
446429000 usd
us-gaap Net Income Loss
NetIncomeLoss
144341000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25932000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24049000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
41647000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
23932000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-11000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-815000 usd
us-gaap Inventory Write Down
InventoryWriteDown
31441000 usd
us-gaap Inventory Write Down
InventoryWriteDown
13875000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3253000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
882000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2497000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
8157000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-78629000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-3230000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
649000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1007000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-165894000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
216464000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
26254000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
561453000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-15088000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
32750000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-9120000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
173031000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
50855000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
4672000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
76062000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
27434000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-62639000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4644000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-3883000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-8892000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
672919000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-415658000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28618000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34157000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1100000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28618000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35257000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
164326000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
938075000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
570446000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
480795000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
24822000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15951000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
19442000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6807000 usd
smci Payments For Repurchase And Retirement Of Common Stock
PaymentsForRepurchaseAndRetirementOfCommonStock
146526000 usd
smci Payments For Repurchase And Retirement Of Common Stock
PaymentsForRepurchaseAndRetirementOfCommonStock
0 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-25000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-59000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-547291000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
466365000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2269000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-304000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
94741000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15146000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
268559000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
233449000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
363300000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
248595000 usd
us-gaap Interest Paid Net
InterestPaidNet
7223000 usd
us-gaap Interest Paid Net
InterestPaidNet
2990000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
107054000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
11623000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2885000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7464000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1679000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
11108000 usd
smci Stock Repurchased Not Paid
StockRepurchasedNotPaid
3472000 usd
smci Stock Repurchased Not Paid
StockRepurchasedNotPaid
0 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentration of Supplier RiskCertain materials used by the Company in the manufacturing of its products are available from a limited number of suppliers.Concentration of Credit RiskFinancial instruments which potentially subject the Company to concentration of credit risk consist primarily of cash and cash equivalents, restricted cash, investment in an auction rate security and accounts receivable.
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1283296000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1355490000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4938621000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3560639000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1283296000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1355490000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4938621000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3560639000 usd
us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
Generally, the payment terms of the Company’s offerings range from 30 to 60 days.
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
233800000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
25200000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
86200000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
76100000 usd
smci Contract With Customer Liability Increase Decrease For Non Cancellable Non Refundable Advance Consideration Or Cash Consideration
ContractWithCustomerLiabilityIncreaseDecreaseForNonCancellableNonRefundableAdvanceConsiderationOrCashConsideration
2400000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
309900000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.48
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
85846000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
85846000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
76972000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
76972000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
446429000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
446429000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
144341000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
144341000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53280000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51708000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53011000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51269000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2953000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2078000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2785000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2132000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56233000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53786000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55796000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53401000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.61
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.82
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.53
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.43
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.70
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1075482000 usd
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1025555000 usd
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
159994000 usd
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
209576000 usd
CY2023Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
304943000 usd
CY2022Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
310475000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
1540419000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
1545606000 usd
CY2023Q1 smci Inventory Write Down Excluding Write Down To Net Realizable Value
InventoryWriteDownExcludingWriteDownToNetRealizableValue
6000000 usd
smci Inventory Write Down Excluding Write Down To Net Realizable Value
InventoryWriteDownExcludingWriteDownToNetRealizableValue
31400000 usd
CY2022Q1 smci Inventory Write Down Excluding Write Down To Net Realizable Value
InventoryWriteDownExcludingWriteDownToNetRealizableValue
10200000 usd
smci Inventory Write Down Excluding Write Down To Net Realizable Value
InventoryWriteDownExcludingWriteDownToNetRealizableValue
13900000 usd
CY2023Q1 smci Accounts Receivable Vendor Current
AccountsReceivableVendorCurrent
110712000 usd
CY2022Q2 smci Accounts Receivable Vendor Current
AccountsReceivableVendorCurrent
138054000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8724000 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5632000 usd
CY2023Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
6476000 usd
CY2022Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
5562000 usd
CY2023Q1 us-gaap Prepaid Taxes
PrepaidTaxes
1522000 usd
CY2022Q2 us-gaap Prepaid Taxes
PrepaidTaxes
2352000 usd
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
251000 usd
CY2023Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
12466000 usd
CY2022Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
6948000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
139900000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
158799000 usd
CY2023Q1 smci Accounts Receivable Manufacturer Current
AccountsReceivableManufacturerCurrent
81000000 usd
CY2022Q2 smci Accounts Receivable Manufacturer Current
AccountsReceivableManufacturerCurrent
98900000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
362801000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
267397000 usd
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
251000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
499000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
911000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
363300000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
268559000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
477131000 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
453730000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
187093000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
167758000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
290038000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
285972000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19514000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23679000 usd
CY2023Q1 us-gaap Deferred Costs
DeferredCosts
9315000 usd
CY2022Q2 us-gaap Deferred Costs
DeferredCosts
6316000 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
2494000 usd
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
5329000 usd
CY2023Q1 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
1908000 usd
CY2022Q2 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
2011000 usd
CY2023Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1729000 usd
CY2022Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1069000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
1590000 usd
CY2022Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
1590000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
499000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
911000 usd
CY2023Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1784000 usd
CY2022Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1956000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
38833000 usd
CY2022Q2 us-gaap Other Assets
OtherAssets
42861000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
34058000 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
57736000 usd
CY2023Q1 smci Payable Manufacturer
PayableManufacturer
30013000 usd
CY2022Q2 smci Payable Manufacturer
PayableManufacturer
41125000 usd
CY2023Q1 smci Accrued Customer Deposits Current
AccruedCustomerDepositsCurrent
18152000 usd
CY2022Q2 smci Accrued Customer Deposits Current
AccruedCustomerDepositsCurrent
30421000 usd
CY2023Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
9704000 usd
CY2022Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
9073000 usd
CY2023Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
9000000 usd
CY2022Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
8757000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7143000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7139000 usd
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1867000 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4281000 usd
CY2023Q1 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
0 usd
CY2022Q2 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
18250000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
45287000 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
35637000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
155224000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
212419000 usd
CY2021Q2 smci Performance Bonus Liability Tranche Two
PerformanceBonusLiabilityTrancheTwo
4000000 usd
CY2021Q2 smci Performance Bonus Liability Tranche One
PerformanceBonusLiabilityTrancheOne
3600000 usd
CY2021Q3 smci Reduced Payment For Performance Bonus Tranche One
ReducedPaymentForPerformanceBonusTrancheOne
2000000 usd
CY2021Q2 smci Performance Bonus Liability Tranche One
PerformanceBonusLiabilityTrancheOne
3600000 usd
CY2021Q3 smci Performance Bonus Liability Tranche One
PerformanceBonusLiabilityTrancheOne
2000000 usd
CY2021Q3 smci Benefit From Performance Bonus Adjustment Tranche One
BenefitFromPerformanceBonusAdjustmentTrancheOne
1600000 usd
smci Bonus Compensation Expense Benefit
BonusCompensationExpenseBenefit
0 usd
CY2023Q1 smci Bonus Compensation Expense Benefit
BonusCompensationExpenseBenefit
0 usd
CY2022Q1 smci Bonus Compensation Expense Benefit
BonusCompensationExpenseBenefit
0 usd
smci Bonus Compensation Expense Benefit
BonusCompensationExpenseBenefit
1600000 usd
CY2023Q1 smci Accrued Unrecognized Tax Benefits Including Related Interestsand Penalties Noncurrent
AccruedUnrecognizedTaxBenefitsIncludingRelatedInterestsandPenaltiesNoncurrent
18865000 usd
CY2022Q2 smci Accrued Unrecognized Tax Benefits Including Related Interestsand Penalties Noncurrent
AccruedUnrecognizedTaxBenefitsIncludingRelatedInterestsandPenaltiesNoncurrent
18866000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12668000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16661000 usd
CY2023Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
5268000 usd
CY2022Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
3064000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
439000 usd
CY2022Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
549000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
37240000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
39140000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
13276000 usd
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11583000 usd
CY2022Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12136000 usd
CY2021Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12863000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
9419000 usd
CY2022Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
7514000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
26969000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
19956000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
8100000 usd
CY2022Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
7797000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
25126000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
21717000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
377000 usd
CY2022Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
695000 usd
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
993000 usd
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
893000 usd
CY2022Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1200000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
14972000 usd
CY2022Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11995000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
14972000 usd
CY2022Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11995000 usd
CY2023Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
9704000 usd
CY2022Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
9322000 usd
CY2023Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
9704000 usd
CY2022Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
9322000 usd
CY2023Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
5268000 usd
CY2022Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
2673000 usd
CY2023Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
5268000 usd
CY2022Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
2673000 usd
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1200000 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2022Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2023Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
187207000 usd
CY2022Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
596764000 usd
CY2023Q1 smci Short Term Debt And Long Term Debt Current Maturities
ShortTermDebtAndLongTermDebtCurrentMaturities
53972000 usd
CY2022Q2 smci Short Term Debt And Long Term Debt Current Maturities
ShortTermDebtAndLongTermDebtCurrentMaturities
449146000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
133235000 usd
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
147618000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
25526000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
39260000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
43253000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
43253000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
18791000 usd
CY2023Q1 smci Long Term Debt Maturities Repayments Of Principal In After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInAfterYearFour
17124000 usd
CY2023Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
187207000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
2129000 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
2017000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
6354000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
6183000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2146000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1854000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
6209000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
6067000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
655000 usd
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3730000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1679000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
11108000 usd
CY2023Q1 us-gaap Variable Lease Payment
VariableLeasePayment
500000 usd
us-gaap Variable Lease Payment
VariableLeasePayment
1300000 usd
CY2022Q1 us-gaap Variable Lease Payment
VariableLeasePayment
200000 usd
us-gaap Variable Lease Payment
VariableLeasePayment
700000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M12D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.030
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2222000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7272000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6627000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2683000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1566000 usd
CY2023Q1 smci Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
536000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
20906000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1095000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
19811000 usd
CY2022Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
200000000 usd
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1553350 shares
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
150000000 usd
CY2023Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
50000000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13652000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7741000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
41647000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23932000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3444000 usd
CY2022Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2431000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
8165000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
8077000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
10208000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
5310000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
33482000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
15855000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4311416 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
29.99
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
336082 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
66.25
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1205727 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
20.59
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
21568 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
30.18
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3420203 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
36.87
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M25D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2136763 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
30.76
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y3D
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10900000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
79400000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16200000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27100000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.111
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.150
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.174
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.159
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
41300000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
23500000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
2400000 usd
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
2400000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
3400000 usd
CY2023Q1 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
3000000 usd
CY2018Q1 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
2 claim
CY2022Q2 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
18250000 usd
CY2022Q2 smci Litigation Settlement Settlement Funds To Be Distributed Before Final Court Approval
LitigationSettlementSettlementFundsToBeDistributedBeforeFinalCourtApproval
0 usd
CY2023Q1 us-gaap Purchase Obligation
PurchaseObligation
932800000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
290038000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
285972000 usd

Files In Submission

Name View Source Status
0001375365-23-000028-index-headers.html Edgar Link pending
0001375365-23-000028-index.html Edgar Link pending
0001375365-23-000028.txt Edgar Link pending
0001375365-23-000028-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
option_notice-feb2023updat.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
smci-20230331.htm Edgar Link pending
smci-20230331.xsd Edgar Link pending
smci-20230331_g1.jpg Edgar Link pending
smci-ex311_20230331x10q.htm Edgar Link pending
smci-ex312_20230331x10q.htm Edgar Link pending
smci-ex321_20230331x10q.htm Edgar Link pending
smci-ex322_20230331x10q.htm Edgar Link pending
smci-20230331_cal.xml Edgar Link unprocessable
smci-20230331_lab.xml Edgar Link unprocessable
smci-20230331_def.xml Edgar Link unprocessable
smci-20230331_pre.xml Edgar Link unprocessable
smci-20230331_htm.xml Edgar Link completed